Parkinson's Europe

A particularly active area of research is the development of molecular imaging biomarkers that can be used in combination with common neuroimaging approaches. In the latest episode of The Parkinson’s Research Podcast, Antonio P. Strafella, MD, PhD, FRCPC, director of clinical research and translation at Temerty Faculty of Medicine, University of Toronto shares how molecular imaging biomarkers are being used in research and in the clinic. He discusses the process of developing new biomarkers, promising biomarkers that are currently in development, limitations, implementation challenges and the potential use of AI to enhance diagnostics in the future. Listen now: https://bit.ly/4cUf4bA * This podcast is geared toward researchers and clinicians. If you live with Parkinson’s or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson’s Podcast: https://bit.ly/3W1iKBa

New MDS paper: Experts identify the major gaps that are barriers to understanding alpha-synuclein's role in PD. https://loom.ly/G3NHMR8

This is why we work in the NHS. At Sherwood Forest Hospitals, improving people's lives and experience of care is at the heart of what matters to us. We love this before and after video showing the life-changing impact that a new treatment for Parkinson's disease is making to one of our patients. We are the first hospital in the East Midlands to offer Produodopa, a new infusion therapy treatment that is administered via a portable pump under the skin, for patients with advanced-stage Parkinson's disease. Damien Gath, 52, of Derby, underwent the treatment at Sherwood Forest Hospitals. Damien’s condition had recently worsened and he had been taking four separate oral drugs six times a day to control the problematic involuntary movements which made those everyday activities a challenge. Damien said: “It’s been extraordinary and life-changing – just shortly after first having the treatment I was able make a cup of coffee more easily and go to the supermarket.” Dr Nishantha Silva, Consultant Geriatrician and Service lead for Parkinson’s disease and related movement disorders at SFH, said: “We are proud to be the first Trust in the East Midlands to offer this and aim to build on this success by expanding access to Produodopa, ensuring that more patients can experience its benefits, providing our patients with the highest quality of care and latest treatment options. “The successful implementation of Produodopa at SFH heralds a new era in the management of advanced Parkinson’s disease.” You can read more about Damien's experiences on our website at https://lnkd.in/gfEZdz-B If you'd like to join #TeamSFH, check out our vacancies for jobs at all levels and across all departments at https://lnkd.in/e8E76D_5. NHS England

Attending #AAIC24? Don't miss presentations on the latest EPND #biomarker research, from our partners Pieter Jelle Visser, Betty Tijms and Marianna Rizzo! 📍 Marianna Rizzo of Maastricht University will share the latest results from a collaborative EPND study on ATN #biomarkers, involving samples from 337 individuals with #Alzheimers, #Parkinsons or #dementia with Lewy bodies, from 6 centers across #Europe. ➡ Featured Research Session on fluid biomarkers in Lewy body disease: room 115ABC, Sunday 28 July, 14.30-14.45 📍 On Sunday afternoon, Betty Tijms of Amsterdam UMC will present her work on #Alzheimers disease subtypes, identified through #proteomics analysis of CSF samples. ➡ Featured Research Session on "The Atypical Alzheimer’s Disease Continuum: from Clinical Phenotypes to Disease Mechanisms": room 115ABC, Sunday 28 July, 16.45-17.00 📍 Next Tuesday, visit poster 342 to learn about the relationship between tau levels, proteomic #biomarker signatures and progression to #dementia in people with mild cognitive impairment - from EPND co-Lead, Pieter Jelle Visser. ➡ Tuesday 30 July, Exhibit Hall AB, 08.00 - 16.15 Innovative Health Initiative (IHI) EFPIA - European Federation of Pharmaceutical Industries and Associations Alzheimer's Association®

Join us on Tuesday, 8/13 to learn about future-proofing today's home for tomorrow's needs. Suz Klyber & Greg Sieb are the dynamic duo behind Live In Plaace which has helped over 5,000 families in need since 2007. They are going to discuss: - Good Body Mechanics - Importance of Fall Prevention - Energy Conservation techniques - Home modifications versus remodeling or doing a combination Suz has 40 year's experience as an occupational therapist with 26 years focused on in-hoe care. Greg has vast experience in construction, customer service and project management. Register Online Today: https://lnkd.in/euWAxpKk #yopd #parkinsons

Are you a healthcare professional interested in the journey of patients and caregivers dealing with Parkinson’s Disease? If so, join our international and national faculty on November 23 to discuss the many challenges involved! Registrations are now open: https://lnkd.in/di9m9Q3H The 6th edition of the MOVING ON SERIES also invites you to submit an abstract for a chance to be selected for an oral presentation, win a prize, and have your abstract published in SINAPSE. Please check our abstract submission details: https://lnkd.in/dUc_7cUc This edition of MOVING ON SERIES is a joint session by Sociedade Portuguesa de Neurologia (SPN), Sociedade Portuguesa das Doenças do Movimento (SPDMov) and BIAL. #BIAL #BIALKeepingLifeinMind #InspiredByTheFuture

“There's so much to take away from the experience of being in such a simple yet hostile environment, throwing everything at you, testing your very spirit, resolve and strength, but knowing you can do it,” says Brendan Cusick, captain of Team Human Powered Potential. “I knew I could do it because I had three amazing humans next to me and had what was in my heart, mind and spirit. It's untapped what any human can do if you just put your heart and mind to it.” Successfully completing the World's Toughest Row on July 19 after enduring over 41 days of rigorous rowing and unpredictable weather, Team HPP has proven that with determination, unity and compassion, extraordinary feats are possible. In the end, it was the team members’ unwavering spirit, combined with support from the Parkinson’s community, that propelled them to the finish line. With each stroke, Team HPP aimed to honor those living with Parkinson’s and raise $28 million for research. They set a race record, raising $9,000 per mile — totaling over $25 million raised to date — thanks to a historic 3:1 match from an anonymous donor. Learn more about their incredible journey and mission to find a cure for Parkinson’s: https://bit.ly/3yj92SQ 📽️: World's Toughest Row